Where do you start when developing a new lateral flow test for early detection of prostate cancer, especially when you don't have full access to a lab?

In this episode of Bringing new ideas to life, Sarah Allison interviews Tiffany Ma, CEO and co-founder of GambitBio. Tiffany explains how Gambit Bio is developing a self-test kit for early cancer detection using saliva. Inspired by the accessibility of self-testing during the COVID-19 pandemic, Tiffany and her co-founders aim to make cancer detection easier and more accessible.

Listen to how Gambit took shape, the startup challenges encountered and the exciting plans for the future.

Timestamps

The idea behind Gambit Bio [00:01:17] Explanation the inspiration behind GambitBio, a startup developing a self-test kit for early cancer detection.

The innovation: a home self-test kit for cancer detection [00:02:22] The innovation behind GambitBio, a home self-test kit for early cancer detection using saliva as a sample.

Challenges and funding [00:08:32] The challenges of starting a startup without lab support and explains how they gathered funds through angel funding, competitions, and accelerator programmes.

Advice for starting a startup [00:14:01] Tiffany shares her advice for starting a startup, including the importance of taking action and seeking advice from people who have been in your shoes.

Future plans for Gambit Bio [00:15:32] Tiffany discusses her plans to raise money for Gambit Bio's seed round and bring a self-test kit for prostate cancer to the market, with the goal of expanding to other cancer types in the future.

Sarah Allison, is a Senior Consultant, Tiffany Ma, CEO GambitBio

Contact us with any questions at [email protected]

Episode transcript

Hosted on Acast. See acast.com/privacy for more information.